PMA device
Cellugel(R) Ophthalmic Viscosurgical Device
Alcon Laboratories · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Feb 24, 2000, newest Sep 9, 2016Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
0
Naming "Cellugel Ophthalmic Viscosurgical"
MAUDE reports
31
Brand "Cellugel Ophthalmic Viscosurgical", since 2015
PubMed studies
0
Mentioning "Cellugel Ophthalmic Viscosurgical"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cellugel(R) Ophthalmic Viscosurgical Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- CELLUGEL(R) OPHTHALMIC VISCOSURGICAL DEVICEPMA supplement
P990023-S016 · Decided Sep 9, 2016 · 84 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- CELLUGEL OPHTHALMIC VISCOSURGICAL DEVICE (OVD)PMA supplement
P990023-S013 · Decided Feb 18, 2016 · 301 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
P990023 · Decided Feb 24, 2000 · 293 days after receipt
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cellugel Ophthalmic Viscosurgical", any status and sponsor, newest update first.
No registered device study names "Cellugel Ophthalmic Viscosurgical".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cellugel Ophthalmic Viscosurgical", and for the whole product code for context.
This brand
31 reports: 16 malfunction, 15 injury, 0 death
Whole product code LZP
1,607 reports: 550 malfunction, 1,056 injury, 0 death
Newest reports for this brand
ALCON - COUVREUR N.V./ALCON - BELGIUM
3002037047-2025-00019 · Received Feb 25, 2025 · Event dated Dec 1, 2023
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Corneal Edema
ALCON - COUVREUR N.V./ALCON - BELGIUM
3002037047-2025-00020 · Received Feb 25, 2025 · Event dated Jan 1, 2024
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Corneal Edema
ALCON - COUVREUR N.V./ALCON - BELGIUM
3002037047-2025-00011 · Received Feb 24, 2025 · Event dated Dec 1, 2023
Device type: Aid, Surgical, Viscoelastic (LZP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Intraocular Pressure Increased
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Cellugel Ophthalmic Viscosurgical"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LZP.
- PROVISC Ophthalmic Viscosurgical DeviceAlcon Research, Ltd. · PMA 2026
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- Staarvisc II & Shellgel Sodium HyauronateAnika Therapeutics, Inc. · PMA 2012
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- DISCOVISC Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2021
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
- Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)Altacor , Ltd. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.